Keros Therapeutics, Inc.
Ticker: 1664710
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 40.01+10713.5% | 0.37-97.4% | 14.26-21.5% | 18.17-91.4% | 211.25+54066.7% | 0.39+875.0% | 0.04-50.0% | 0.08 |
| Total Income | 40.01+10713.5% | 0.37-97.4% | 14.26-21.5% | 18.17-91.4% | 211.25+54066.7% | 0.39+875.0% | 0.04-50.0% | 0.08 |
| EXPENSES | ||||||||
| Expenditure | 27.19+3.6% | 26.24-11.5% | 29.65-48.9% | 57.99-2.1% | 59.21+0.3% | 59.05+17.0% | 50.48+3.9% | 48.57 |
| Tax | 0.77 | 0.00+100.0% | -1.42+36.0% | -2.22-122.1% | 10.04 | — | — | — |
| PROFIT | ||||||||
| PBT | 14.93+163.0% | -23.71-172.5% | -8.70+73.6% | -32.92-120.8% | 158.49 | — | — | — |
| Net Profit | 14.15+159.7% | -23.71-225.7% | -7.28+76.3% | -30.70-120.7% | 148.45+380.3% | -52.96-17.0% | -45.26-5.0% | -43.11 |
| KEY METRICS | ||||||||
| OPM % | 32.04%+132.04pp | -100.00% | -100.00% | -100.00%-171.97pp | 71.97%+171.97pp | -100.00% | -100.00% | -100.00% |
| NPM % | 35.38%+135.37pp | -100.00%-48.95pp | -51.05%+48.95pp | -100.00%-170.27pp | 70.27%+170.27pp | -100.00% | -100.00% | -100.00% |
| EPS | 0.71+158.7% | -1.21-572.2% | -0.18+76.3% | -0.76-120.8% | 3.66+359.6% | -1.41-12.8% | -1.25-3.3% | -1.21 |
Corporate Events
Board MeetingKROS
202617Jul
Board Meeting
CFO Transition — Keith Regnante resigned as CFO; Annita Tani…
SEC Filing ↗ Board MeetingKROS
20261Jul
Board Meeting
Appointment of Anne Prener, M.D., Ph.D., as a Class III dire…
SEC Filing ↗ Board MeetingKROS
20263Jun
Board Meeting
2026 Annual Meeting of Stockholders to elect directors, rati…
SEC Filing ↗